Valeritas files U.S. application for use of regular insulin with V-Go device

Valeritas Holdings (VLRX -2.4%) has filed a supplemental marketing application [called a Special 510(k)] with the FDA seeking clearance to use regular human insulin with its wearable V-Go device. The company says the expanded use, if approved, will save patients money.

V-Go is currently cleared for use with a U100 fast-acting insulin, like rapid-acting insulin analogs, which is more expensive.

https://seekingalpha.com/news/3474332-valeritas-files-u-s-application-use-regular-insulin-v-go